Literature DB >> 28600750

Intra-operative hemorrhage due to hyperperfusion during direct revascularization surgery in an adult patient with moyamoya disease: a case report.

Hiroki Uchida1,2, Hidenori Endo3, Miki Fujimura1, Toshiki Endo2, Kuniyasu Niizuma1, Teiji Tominaga1.   

Abstract

Hemorrhagic complication is one of the notable surgical complications of the revascularization surgery for moyamoya disease (MMD). Cerebral hyperperfusion (CHP) has been considered as the underlying cause of this complication. It mostly occurs several days after surgery, but the intra-operative hemorrhage immediately after bypass has not been reported previously. A 21-year-old woman presented right thalamic hemorrhage and was diagnosed as having MMD by cerebral angiography. In light of the location of the hemorrhage at the vascular territory of posterior circulation and the manifestation of transient ischemic attack during the follow-up period, she underwent revascularization surgery to prevent future ischemic attack and rebleeding. Superficial temporal artery (STA) was uneventfully anastomosed to the temporal M4 branch of the middle cerebral artery in an end-to-side manner. A few minutes after the completion of the anastomosis, hemorrhage occurred in the fissure adjacent to the site of anastomosis. Indocyanine green (ICG) video angiography just before hemorrhage showed focal early filling through the STA graft with early venous filling around the site of the anastomosis. The bleeding was controlled by immediate hypotensive therapy (systolic blood pressure 117 to 91 mmHg). The mean blood flows of the STA graft measured by ultrasonic flowmetry before and after hypotensive therapy were 52.8 and 24.2 ml/min, respectively. Single-photon emission computed tomography (SPECT) on the next day after surgery showed focal hyperperfusion in the surgical side. Intra-operative ultrasonic flowmetry, ICG, and postoperative SPECT would explain that CHP was the potential cause of the hemorrhagic complication. This is the first case describing intra-operative hemorrhagic complication during revascularization surgery for MMD. Surgeons need to be aware of this rare complication and its management method.

Entities:  

Keywords:  Direct revascularization surgery; Hemorrhagic complication; Hyperperfusion; Moyamoya disease

Mesh:

Year:  2017        PMID: 28600750     DOI: 10.1007/s10143-017-0868-2

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  22 in total

Review 1.  Cerebral hyperperfusion syndrome.

Authors:  Walther N K A van Mook; Roger J M W Rennenberg; Geert Willem Schurink; Robert Jan van Oostenbrugge; Werner H Mess; Paul A M Hofman; Peter W de Leeuw
Journal:  Lancet Neurol       Date:  2005-12       Impact factor: 44.182

2.  Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography.

Authors:  Miki Fujimura; Hiroaki Shimizu; Takashi Inoue; Shunji Mugikura; Atsushi Saito; Teiji Tominaga
Journal:  Neurosurgery       Date:  2011-04       Impact factor: 4.654

3.  Flow replacement bypass for aneurysms: decision-making using intraoperative blood flow measurements.

Authors:  Sepideh Amin-Hanjani; Ali Alaraj; Fady T Charbel
Journal:  Acta Neurochir (Wien)       Date:  2010-04-06       Impact factor: 2.216

4.  Lessons learned from moyamoya disease: outcome of direct/indirect revascularization surgery for 150 affected hemispheres.

Authors:  Miki Fujimura; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2012       Impact factor: 1.742

5.  Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease.

Authors:  Miki Fujimura; Tomohiro Kaneta; Shunji Mugikura; Hiroaki Shimizu; Teiji Tominaga
Journal:  Surg Neurol       Date:  2007-03

6.  Local Vasogenic Edema without Cerebral Hyperperfusion after Direct Revascularization Surgery for Moyamoya Disease.

Authors:  Hiroyuki Sakata; Miki Fujimura; Shunji Mugikura; Kenichi Sato; Teiji Tominaga
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-05-06       Impact factor: 2.136

7.  Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: possible involvement of cerebral hyperperfusion and increased vascular permeability.

Authors:  Miki Fujimura; Hiroaki Shimizu; Shunji Mugikura; Teiji Tominaga
Journal:  Surg Neurol       Date:  2008-03-04

8.  Clinical implications of intraoperative infrared brain surface monitoring during superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.

Authors:  Atsuhiro Nakagawa; Miki Fujimura; Tatsuhiko Arafune; Ichiro Sakuma; Teiji Tominaga
Journal:  J Neurosurg       Date:  2009-12       Impact factor: 5.115

9.  Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.

Authors:  Miki Fujimura; Shunji Mugikura; Tomohiro Kaneta; Hiroaki Shimizu; Teiji Tominaga
Journal:  Surg Neurol       Date:  2008-06-02

10.  Indocyanine green videoangiography for assessment of postoperative hyperperfusion in moyamoya disease.

Authors:  Nobutaka Horie; Yuhtaka Fukuda; Tsuyoshi Izumo; Kentaro Hayashi; Kazuhiko Suyama; Izumi Nagata
Journal:  Acta Neurochir (Wien)       Date:  2014-03-14       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.